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Response to “Are fluids resuscitation the
“Keyser Soze” of acute kidney injury in
trauma patients?”
Anatole Harrois1* , Benjamin Soyer1, Tobias Gauss2, Sophie Hamada1, Mathieu Raux3, Jacques Duranteau1 and for
the Traumabase® Group
See related letter by Jamme and Salem, https://ccforum.biomedcentral.com/articles/10.1186/s13054-019-2333-9
We appreciate the interest expressed by Dr. Jamme and
Ben Hadj Salem in our study recently published in crit-
ical care reporting the prevalence and the risk factors of
acute kidney injury (AKI) in a multicentre cohort of
3111 trauma patients [1]. The issue they raised was the
lack of data on fluid resuscitation, especially regarding
the amount of crystalloids and colloids. We share with
the authors the view that the choice of fluid is a critical
issue to prevent AKI in trauma patients. Indeed, recent
studies have called into question the safety of colloids
[2] in trauma patients as well as the safety of NaCl 0.9%
in ICU patients [3]. Our database provides data on pre-
hospital fluid resuscitation for the whole study cohort as
well as data on 24-h fluid resuscitation for hemorrhagic
shock patients (n = 355, 11%).
Nineteen percent of the 3111 study patients received
colloids (median volume of 500 mL [IQR 500–750])
while 94% of the 3111 study patients received crystal-
loids (median volume of 500 mL [IQR 500–1000]) dur-
ing the prehospital period. When the volume of colloids
or crystalloids administered in the prehospital setting
was forced into the predictive model of AKI (all stages
of RIFLE classification), odd ratios were respectively (per
1000 mL of solution) 1.34 (CI 0.85–2.12, p = 0.21) and
1.11 (CI 0.84–1.45, p = 0.47). Thus, prehospital fluid re-
suscitation does not provide additional value to early
predict AKI. Longer period of exposure might be worth
considering to capture the potential nephrotoxic effect
of fluid on renal function; however, as our main object-
ive was to early predict AKI after trauma, we believe it
would make the model less relevant.
Eighty-seven percent of hemorrhagic shock patients
received colloids over the first 24 h of care (median vol-
ume of 1000 mL [IQR 500–2000]). Though only 9.6% of
them received a dose higher than 33 mL/kg, we cannot
rule out that colloids caused renal toxicity in our
study cohort. In the meantime, patients received a
median volume of 3500 mL [IQR 2000–6000] of cris-
talloids. Our database does not distinguish the various
types of cristalloids and provides no data on hyper-
chloremia to indirectly assess the administered vol-
ume of NaCl 0.9%. However, at the time of the study,
the three centres were using, though not exclusively,
NaCl 0.9% for fluid resuscitation. Given the large
amount of administered crystalloids in hemorrhagic
shock patients, we cannot exclude that chloride-rich
fluids worsened renal aggression.
As shown in Fig. 1, colloid use has declined over the last
few years while crystalloids remain the cornerstone for
fluid resuscitation in trauma patients. In order to prevent
nephrotoxicity related to NaCl 0.9%, isotonic-balanced
crystalloids have been proposed for fluid resuscitation, in-
cluding for patients with traumatic brain injury [4]. How-
ever, further studies are necessary to assess if this practice
translates to better outcome in trauma patients. We are
about to start such a study (NCT03630224).
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